Sodium-glucose cotransporter-2 inhibitors for heart failure with reduced ejection fraction
Can Fam Physician
.
2021 Sep;67(9):678.
doi: 10.46747/cfp.6709678.
Authors
Jamie Falk
1
,
Jennifer Potter
2
,
Ricky D Turgeon
3
Affiliations
1
Associate Professor in the College of Pharmacy at the University of Manitoba in Winnipeg.
2
Family physician in Winnipeg.
3
Assistant Professor in the Faculty of Pharmaceutical Sciences at the University of British Columbia in Vancouver.
PMID:
34521711
PMCID:
PMC9683368
DOI:
10.46747/cfp.6709678
No abstract available
MeSH terms
Heart Failure* / drug therapy
Humans
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use
Stroke Volume
Substances
Sodium-Glucose Transporter 2 Inhibitors